Reverse total shoulder arthroplasty for acute proximal humeral fracture has comparable 10-year outcomes to elective indications: results from the New Zealand Joint Registry
Journal of Shoulder and Elbow Surgery · 2024
DOI: 10.1016/j.jse.2024.01.024 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Shoulder and Elbow Surgery, 2024. Verfasst von Scott M Bolam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Auckland, Grafton, Auckland, New Zealand; Department of Orthopedic Surgery, Auckland City Hospital, Grafton, Auc…. Hauptthemen laut MEDLINE: Shoulder Fractures, Registries, Arthroplasty, Replacement, Shoulder, Elective Surgical Procedures. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
HYPOTHESIS AND BACKGROUND: Recently, the indication of reverse total shoulder arthroplasty (RTSA) has expanded beyond rotator cuff arthropathy to include treatment of complex acute proximal humeral fracture (PHF). Limited previous studies have compared the long-term clinical and functional outcomes of patients undergoing RTSA for PHF vs. elective indications for degenerative conditions. The purpose of this study was to compare implant survivorship, reasons for revision and functional outcomes in patients undergoing RTSA for acute PHF with those undergoing elective RTSA in a population-based cohort study. METHODS: Prospectively collected data from the New Zealand Joint Registry from 1999 to 2021 and identified 6862 patients who underwent RTSA. Patients were categorized by preoperative indication, including PHF (10.8%), rotator cuff arthropathy (RCA) (44.5%), osteoarthritis (OA) (34.1%), rheumatoid arthritis (RA) (5.5%), and old traumatic sequelae (5.1%). Revision-free implant survival and functional outcomes (Oxford Shoulder Scores [OSSs] at the 6-month, 5-year, and 10-year follow-ups) were adjusted by age, sex, American Society of Anesthesiologists class, and surgeon experience and compared. RESULTS: Revision-free implant survival at 10 years for RTSA for PHF was 97.3%, compared with 96.1%, 93.7%, 92.8%, and 91.3% for OA, RCA, RA and traumatic sequelae, respectively. When compared with RTSA for PHF, the adjusted risk of revision was significantly higher for traumatic sequelae (hazard ratio = 2.3, P = .023) but not for other elective indications. The most common reason for revision in the PHF group was dislocation or instability (42.9%), which was similar to the OA (47.6%) and traumatic sequelae (33.3%) groups. At 6 months post-surgery, OSSs were significantly lower for the PHF group compared with the RCA, OA, and RA groups (31.1 vs. 35.6, 37.7, and 36.5, respectively, P < .001), and similar to traumatic sequelae (31.7, P = .431). At 5 years, OSSs were only significantly lower for PHF compared with OA (37.4 vs. 41.0, P < .001) and there was no difference between the PHF and other groups. At 10 years, there were no significant differences between groups. CONCLUSIONS: RTSA for PHF demonstrated reliable long-term survivorship and functional outcomes compared with elective indications. Despite lower functional outcomes in the early postoperative period for the PHF group, implant survivorship was similar in patients undergoing RTSA for the primary indication of acute PHF compared with RCA, OA, and RA and superior compared to the primary indication of traumatic sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Auckland, Grafton, Auckland, New Zealand; Department of Orthopedic Surgery, Auckland City Hospital, Grafton, Auckland, New Zealand. Electronic address: s.bolam@auckland.ac.nz.
- Department of Surgery, University of Auckland, Grafton, Auckland, New Zealand.
- Department of Surgery, University of Auckland, Grafton, Auckland, New Zealand; Department of Orthopedic Surgery, North Shore Hospital, Takapuna, Auckland, New Zealand.
- Department of Medicine, The University of Otago, Christchurch, New Zealand.
- Department of Orthopedic Surgery, Middlemore Hospital, Otahuhu, Auckland, New Zealand.
- Department of Surgery, University of Auckland, Grafton, Auckland, New Zealand; Department of Orthopedic Surgery, Auckland City Hospital, Grafton, Auckland, New Zealand.
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Bolam, S. M., Wells, Z., Tay, M. L., Frampton, C. M. A., Coleman, B., & Dalgleish, A. (2024). Reverse total shoulder arthroplasty for acute proximal humeral fracture has comparable 10-year outcomes to elective indications: results from the New Zealand Joint Registry. Journal of Shoulder and Elbow Surgery. https://doi.org/10.1016/j.jse.2024.01.024
Vancouver
Bolam SM, Wells Z, Tay ML, Frampton CMA, Coleman B, Dalgleish A. Reverse total shoulder arthroplasty for acute proximal humeral fracture has comparable 10-year outcomes to elective indications: results from the New Zealand Joint Registry. Journal of Shoulder and Elbow Surgery. 2024. doi:10.1016/j.jse.2024.01.024
BibTeX
@article{Bolam2024,
author = {Bolam, Scott M and Wells, Zoe and Tay, Mei Lin and Frampton, Chris M A and Coleman, Brendan and Dalgleish, Adam},
title = {Reverse total shoulder arthroplasty for acute proximal humeral fracture has comparable 10-year outcomes to elective indications: results from the New Zealand Joint Registry},
journal = {Journal of Shoulder and Elbow Surgery},
year = {2024},
doi = {10.1016/j.jse.2024.01.024}
}
EUVIMED